Jw Holdings Total Assets

Latest as of September 2025: ₩1.23 Trillion KRW ≈ $833.08 Million USD

Jw Holdings total assets. Based on the latest financial reports, Jw Holdings (096760) holds total assets worth ₩1.23 Trillion KRW (≈ $833.08 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 096760 market cap for the company's overall valuation and market capitalisation.

Total Assets of Jw Holdings (2007–2024)

Total assets of Jw Holdings from 2007 to 2024. This chart illustrates how Jw Holdings's total assets have evolved over time, based on quarterly financial data. See Jw Holdings stock quote for real-time trading data and today's change.

Jw Holdings - Asset Composition Analysis

Jw Holdings Total Assets Breakdown (December 2024)

Jw Holdings total assets breakdown as of December 2024. Jw Holdings's total assets of ₩1.23 Trillion consist of 33.7% current assets and 66.3% non-current assets.

Asset Category Amount (KRW) % of Total Assets
Cash & Equivalents ₩0.00 3.5%
Accounts Receivable ₩162.38 Billion 13.0%
Inventory ₩161.59 Billion 12.9%
Property, Plant & Equipment ₩0.00 0.0%
Intangible Assets ₩73.47 Billion 5.9%
Goodwill ₩153.17 Billion 12.3%

Asset Composition Trend (2007–2024)

This chart illustrates how Jw Holdings's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is Jw Holdings's working capital to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Jw Holdings's current assets represent 33.7% of total assets in 2024, an increase from 0.0% in 2007.
  • Cash Position: Cash and equivalents constituted 3.5% of total assets in 2024, up from 2.8% in 2007.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 17.0% of total assets, an increase from 12.0% in 2007.
  • Asset Diversification: The largest asset category is accounts receivable at 13.0% of total assets.

Jw Holdings Competitors by Total Assets

Key competitors of Jw Holdings based on total assets are shown below.

Company Country Total Assets
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262
China CN¥9.54 Billion
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211
China CN¥6.44 Billion
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
China CN¥1.54 Billion
Renhe Pharmacy Co Ltd
SHE:000650
China CN¥7.93 Billion
Bide Pharmatech Co. Ltd. A
SHG:688073
China CN¥2.54 Billion
Jianmin Pharmaceutical Group Co Ltd
SHG:600976
China CN¥4.69 Billion
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365
China CN¥2.26 Billion
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
China CN¥25.73 Billion

Jw Holdings - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.88 0.82 0.76
Quick Ratio 0.54 0.57 0.51
Cash Ratio 0.00 0.00 0.00
Working Capital ₩-55.46 Billion ₩-108.73 Billion ₩-146.83 Billion

Jw Holdings - Advanced Valuation Insights

This section examines the relationship between Jw Holdings's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.15
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) 6.3%
Total Assets ₩1.25 Trillion
Market Capitalization $179.35 Million USD

Valuation Analysis

Below Book Valuation: The market values Jw Holdings's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Jw Holdings's assets grew by 6.3% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Jw Holdings (2007–2024)

The table below shows the annual total assets of Jw Holdings from 2007 to 2024.

Year Total Assets Change
2024-12-31 ₩1.25 Trillion
≈ $847.52 Million
+6.32%
2023-12-31 ₩1.18 Trillion
≈ $797.14 Million
+1.61%
2022-12-31 ₩1.16 Trillion
≈ $784.48 Million
+8.61%
2021-12-31 ₩1.07 Trillion
≈ $722.26 Million
-4.73%
2020-12-31 ₩1.12 Trillion
≈ $758.15 Million
-10.03%
2019-12-31 ₩1.24 Trillion
≈ $842.68 Million
-2.52%
2018-12-31 ₩1.28 Trillion
≈ $864.48 Million
-5.60%
2017-12-31 ₩1.35 Trillion
≈ $915.81 Million
+12.93%
2016-12-31 ₩1.20 Trillion
≈ $810.94 Million
+10.51%
2015-12-31 ₩1.08 Trillion
≈ $733.84 Million
+4.52%
2014-12-31 ₩1.04 Trillion
≈ $702.09 Million
+2.13%
2013-12-31 ₩1.01 Trillion
≈ $687.47 Million
-5.82%
2012-12-31 ₩1.08 Trillion
≈ $729.96 Million
-1.61%
2011-12-31 ₩1.09 Trillion
≈ $741.92 Million
+48.57%
2010-12-31 ₩736.86 Billion
≈ $499.36 Million
+3.84%
2009-12-31 ₩709.64 Billion
≈ $480.91 Million
+10.52%
2008-12-31 ₩642.09 Billion
≈ $435.13 Million
+15.71%
2007-12-31 ₩554.89 Billion
≈ $376.04 Million
--

About Jw Holdings

KO:096760 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$179.35 Million
₩264.65 Billion KRW
Market Cap Rank
#16747 Global
#632 in Korea
Share Price
₩3825.00
Change (1 day)
-1.42%
52-Week Range
₩3350.00 - ₩4470.00
All Time High
₩26485.64
About

JW Holdings Corporation, together with its subsidiaries, operates as a healthcare company in South Korea, the United States, Japan, China, and internationally. The company offers amino acid solutions, gastrointestinal agents, wound care, eye care, liver disease treatment, cold medicine, API, oral and topical analgesic, and other miscellaneous pharmaceutical products. It also offers hairdye, hair … Read more